Impact of dyslipidemia type and atorvastatin on serum phospholipid essential fatty acid composition

Omega-3 and omega-6 essential fatty acid (EFA) serum levels have been variously associated with risk for coronary heart disease (CHD). The factors that affect serum phospholipid (PL) EFA composition are not well-described. Statins reduce risk for CHD, and one of their effects could be to alter EFA composition. Different dyslipidemias are also associated with differences in CHD risk, and this may be partly mediated by effects on EFA status. In...